AnaptysBio, Inc. closed fiscal year 2025 with $364.4M in total assets, $327.2M in total liabilities and $37.2M in shareholder equity. Total assets fell 24.7% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters AnaptysBio, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ANAB Balance Sheet by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-KT | FY2410-KT | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $364.4M-24.7% | $483.8M+7.0% | $452.4M-25.9% | $610.4M-5.1% | $643.1M+54.4% | $416.6M-4.3% | $435.2M-14.5% | $509.0M+54.5% | $329.4M+429.7% | $62.2M | N/A |
| Total Liabilities | $327.2M-20.8% | $413.0M+13.4% | $364.3M+4.6% | $348.3M+21.5% | $286.6M+1346.2% | $19.8M-34.3% | $30.2M+33.4% | $22.6M+3.9% | $21.8M-78.3% | $100.4M | N/A |
| Total Equity | $37.2M-47.5% | $70.9M-19.6% | $88.1M-66.4% | $262.1M-26.5% | $356.4M-10.2% | $396.7M-2.0% | $405.0M-16.7% | $486.4M+58.1% | $307.6Mn/m | -$38.2Mn/m | -$35.2M |
ANAB Balance Sheet by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q1'2610-Q | Q4'2510-KT | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-KT | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $307.0M-6.9% | $317.0M-13.0% | $329.7M-21.9% | $364.4M-24.7% | $353.1M-28.4% | $335.3M-21.6% | $422.1M+4.0% | $483.8M+7.0% | $493.4M+1.3% | $427.4M-17.4% | $405.8M-26.5% | $452.4M-25.9% |
| Total Liabilities | $286.2M-9.7% | $306.4M-6.4% | $316.9M-18.3% | $327.2M-20.8% | $382.5M-6.5% | $380.0M-9.0% | $388.0M+8.4% | $413.0M+13.4% | $409.1M+11.5% | $417.5M+13.3% | $358.1M-0.7% | $364.3M+4.6% |
| Total Equity | $20.8M+63.3% | $10.6M-71.6% | $12.7M-62.5% | $37.2M-47.5% | -$29.4M-134.9% | -$44.7M-552.8% | $34.0M-28.8% | $70.9M-19.6% | $84.4M-29.9% | $9.9M-93.3% | $47.8M-75.0% | $88.1M-66.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More AnaptysBio, Inc. financials
Frequently Asked Questions
AnaptysBio, Inc. closed fiscal year 2025 with $364.4M in total assets, $327.2M in total liabilities and $37.2M in shareholder equity.
AnaptysBio, Inc. (ANAB) total assets fell by 24.7% year over year, from $483.8M to $364.4M in fiscal year 2025.
AnaptysBio, Inc. (ANAB) reported $307.0M in total assets in Q1 2027. This represents a decrease of 6.9% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what AnaptysBio, Inc. (ANAB) reported on that line in every period on record.